Correlation Between Verona Pharma and YS Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Verona Pharma and YS Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verona Pharma and YS Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verona Pharma PLC and YS Biopharma Co, you can compare the effects of market volatilities on Verona Pharma and YS Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verona Pharma with a short position of YS Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verona Pharma and YS Biopharma.

Diversification Opportunities for Verona Pharma and YS Biopharma

0.12
  Correlation Coefficient

Average diversification

The 3 months correlation between Verona and YS Biopharma is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Verona Pharma PLC and YS Biopharma Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on YS Biopharma and Verona Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verona Pharma PLC are associated (or correlated) with YS Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of YS Biopharma has no effect on the direction of Verona Pharma i.e., Verona Pharma and YS Biopharma go up and down completely randomly.

Pair Corralation between Verona Pharma and YS Biopharma

Given the investment horizon of 90 days Verona Pharma PLC is expected to generate 0.41 times more return on investment than YS Biopharma. However, Verona Pharma PLC is 2.41 times less risky than YS Biopharma. It trades about -0.01 of its potential returns per unit of risk. YS Biopharma Co is currently generating about -0.08 per unit of risk. If you would invest  2,035  in Verona Pharma PLC on March 21, 2024 and sell it today you would lose (485.00) from holding Verona Pharma PLC or give up 23.83% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy26.69%
ValuesDaily Returns

Verona Pharma PLC  vs.  YS Biopharma Co

 Performance 
       Timeline  
Verona Pharma PLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Verona Pharma PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Verona Pharma is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
YS Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days YS Biopharma Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, YS Biopharma is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Verona Pharma and YS Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Verona Pharma and YS Biopharma

The main advantage of trading using opposite Verona Pharma and YS Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verona Pharma position performs unexpectedly, YS Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in YS Biopharma will offset losses from the drop in YS Biopharma's long position.
The idea behind Verona Pharma PLC and YS Biopharma Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets